Cargando…

Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma: A population-based real-world study

Intensity-modulated radiotherapy (IMRT) is widely applied during the treatment of esophageal squamous cell carcinoma (ESCC), but the optimal radiation dose still lacks a consensus. The aim of this study was to explore the optimal radiation dose for inoperable locally advanced ESCC patients treated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Xie, Qing, Zhu, Bifa, Wang, Xiaokang, He, Ling, Zhang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276196/ https://www.ncbi.nlm.nih.gov/pubmed/35482986 http://dx.doi.org/10.1097/MD.0000000000029166

Ejemplares similares

Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma
por: Luo, Hua-Chun, et al.
Publicado: (2023)

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer
por: Li, Can, et al.
Publicado: (2020)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

Postoperative radiotherapy for the young–old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience
por: Ding, Wei, et al.
Publicado: (2020)

Intensity modulated radiotherapy might be effective for locally advanced esophageal carcinosarcoma: A single center’s experience and review of literature
por: Yang, Siran, et al.
Publicado: (2022)

Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancer
por: Lv, Yajuan, et al.
Publicado: (2020)

Effects of preoperative radiotherapy on survival of patients with stage II and III esophageal squamous cell carcinoma: A population-based study
por: Dong, Jing, et al.
Publicado: (2021)

Esophageal peripheral T-cell lymphoma treated with radiotherapy: A case report
por: Zhang, Qiujing, et al.
Publicado: (2021)

Comparing Treatment Plan in All Locations of Esophageal Cancer: Volumetric Modulated Arc Therapy versus Intensity-Modulated Radiotherapy
por: Lin, Jang-Chun, et al.
Publicado: (2015)

Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study
por: Zhao, Qian, et al.
Publicado: (2017)

Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
por: Zhang, Guoqing, et al.
Publicado: (2019)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

A case report of local treatment of inoperable squamous cell lung carcinoma with convex-probe endobronchial ultrasound-guided intratumoral injection of cisplatin in a patient with severe COPD
por: Li, Xiaochen, et al.
Publicado: (2017)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma
por: Sun, Lijun, et al.
Publicado: (2023)

Microvessel density as a prognostic factor in esophageal squamous cell cancer patients: A meta-analysis
por: Ma, Guangzhi, et al.
Publicado: (2017)

Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Surgery and postoperative radiotherapy affect the prognosis of esophageal cancer: A SEER analysis
por: Yang, Wenwen, et al.
Publicado: (2023)

Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy
por: Yang, Jen-Fu, et al.
Publicado: (2016)

High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis
por: He, Shujin, et al.
Publicado: (2019)

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer
por: Han, Dan, et al.
Publicado: (2015)

Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma
por: Zhou, Lu, et al.
Publicado: (2023)

Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis
por: Zhou, Rui, et al.
Publicado: (2020)

A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy
por: Wu, Xun, et al.
Publicado: (2021)

Prognostic value of neutrophil-to-lymphocyte ratio in peripheral blood and pathological tissue in patients with esophageal squamous cell carcinoma
por: Guo, Quanquan, et al.
Publicado: (2020)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma
por: Ma, Junliang, et al.
Publicado: (2022)

Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report
por: Cho, Jaeho, et al.
Publicado: (2008)

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma
por: Lee, Victor H.F., et al.
Publicado: (2017)

S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial
por: Wen, Yixue, et al.
Publicado: (2017)

Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches
por: Li, Hao, et al.
Publicado: (2015)

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma
por: He, Xiao, et al.
Publicado: (2019)

Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2019)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Dosimetric comparison of incidental radiation to the internal mammary nodes after breast-conserving surgery using 3 techniques-inverse intensity-modulated radiotherapy, field-in-field intensity-modulated radiotherapy, and 3-dimensional conformal radiotherapy: A retrospective clinical study
por: Song, Yuanfang, et al.
Publicado: (2019)

Effects of S-1 combined with radiotherapy in the treatment of advanced esophageal cancer: A systematic review and meta-analysis protocol
por: Wang, Wei, et al.
Publicado: (2018)

Brain metastases from esophageal cancer: A retrospective analysis of the outcome after surgical resection followed by radiotherapy
por: Stavrinou, Pantelis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7juk90qdvg3bkpb6o3f3eg09if